This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.

Today's Headlines RSS

BUSINESS

AbbVie Pres. Says Japan Attracting Foreign Investments, Confident in Hep C Drug

James Feliciano assumed office as president of AbbVie GK, the Japan arm of AbbVie Inc., on June 1. Mr Feliciano has been in the pharmaceutical industry in Japan for more ... > Read full story
BUSINESS
Nichi-Iko to Tie Up with Thai Drug Maker to Strengthen Lineup, Accelerate Brand Penetration (Jul.31)
BUSINESS
Nippon Kayaku Initiates PIII Study of Herceptin Biosimilar in Japan (Jul.31)
BUSINESS
Sumitomo Dainippon’s Leigh Syndrome Drug Showed No Statistical Difference in PIIb Study in US (Jul.31)
BUSINESS
Cresemba Fails to Meet Primary Endpoint in PIII Study for Candidemia: Astellas (Jul.31)
BUSINESS
Eisai Files Halaven for Soft Tissue Sarcoma Simultaneously in Japan, US, Europe (Jul.31)
> More Latest News

Photosmore

  
ASCO Immunotherapy Roundup - 4: Merck KGaA Trailing Rivals with ADCC-Inducing Avelumab (Jul.30)New AbbVie Japan Chief Says Generics Making Room for Innovation (Jul.29)Chugai’s Sales Reps to Provide ADR Information on the Spot from Mid-2016 (Jul.29)
  
Drug Pricing Tomorrow: JPA’s Abe Eyes Longer-Term Trial for Key Pricing Premium (Jul.28)St. Marianna Univ. Hospital Introduces Tougher Rules for Adopting New Drugs with Emphasis on Cost, Efficacy, and Safety (Jul.28)Government Approves Basic Policy on Budget Requests for FY2016 (Jul.28)

News Categories

REGULATORY
   AMED Sets Up 5-Step Process to Pick Licensees of Academic Drug Seeds(Jul.30)
   MHLW to Continue Discussions on Elderly Use of Prevenar 13 under National Vaccination Program(Jul.29)
   Finance Minister Calls for Revision of Special Measures on Taxation “Without Preconceptions”(Jul.28)
BUSINESS
   Nichi-Iko to Tie Up with Thai Drug Maker to Strengthen Lineup, Accelerate Brand Penetration(Jul.31)
   Nippon Kayaku Initiates PIII Study of Herceptin Biosimilar in Japan(Jul.31)
   Sumitomo Dainippon’s Leigh Syndrome Drug Showed No Statistical Difference in PIIb Study in US(Jul.31)
ORGANIZATION
Drug Pricing Tomorrow: JPA’s Abe Eyes Longer-Term Trial for Key Pricing Premium(Jul.28)
   No. of Sales Reps Decreases by over 1,000 in FY2014(Jul.28)
Drug Pricing Tomorrow: Full Interview with Kenporen Vice President Shirakawa(Jul.24)
ACADEMIA
   St. Marianna Univ. Hospital Introduces Tougher Rules for Adopting New Drugs with Emphasis on Cost, Efficacy, and Safety(Jul.28)
   PD-L1 Expression Key to Decide Whether to Combine Opdivo, Yervoy: Oncologist(Jul.21)
   Japan, US Oncologists Exchange Barbs over Opdivo Costs(Jul.21)

Commentary

Wholesalers Face Pressing Need to Retool Biz Strategy as Generics Gain Ground

Lexicon

Z2 Rule:
Z2(ゼットツー)

The Column

What’s Your Pharma Company’s Brand in Japan?

Archives

Kyowa Kirin Files NDA for Brodalumab for Psoriasis in Japan(Jul.31)
Kyowa Kirin, BMS to Collaborate in Study of Combination Poteligeo, Opdivo in US(Jul.31)
Delving into Securities Filings - 3: Sales Rep Ratio at Drug Makers Up Slightly in FY2014(Jul.31)
ASCO Immunotherapy Roundup - 4: Merck KGaA Trailing Rivals with ADCC-Inducing Avelumab(Jul.30)
AMED Sets Up 5-Step Process to Pick Licensees of Academic Drug Seeds(Jul.30)

News Calendar